BMD Archives - Spinal Surgery News

24 March 2015

Romosozumab: Bone-forming agent promising for osteoporosis patients

Romosozumab, A new bone-forming agent currently under study by Amgen Inc. and Belgium’s UCB, has shown promise in research into...

and receive all of the latest news via our weekly newsletter

"*" indicates required fields

About Us

Spinal Surgery News online features news, opinions, events, reviews, product information and a wide range of peer-reviewed scientific material of interest to specialist spinal professionals.

The journal has several eminent editorial contributors guiding its content; and we also work closely with companies in the industry to ensure it remains useful and relevant.

BMD

Romosozumab: Bone-forming agent promising for osteoporosis patients

Tethered Spinal Cord Syndrome (TSCS): Pathophysiology and clinical presentation with a focus on anaesthetic management

Physicoll collagen supplement supports holistic post-surgery recovery

Avicenna.AI lands FDA clearance for AI tool that detects cervical spine fracture

Scoliosis Research Society announces recipients for the Lifetime Achievement Award

24th-27th April 2025, NSpine Combined Cadaveric & Live Tissue Training; France

13-17 January 2025, NSpine Winter Masterclass; Switzerland

About Us

BMD

Romosozumab: Bone-forming agent promising for osteoporosis patients

and receive all of the latest news via our weekly newsletter

Tethered Spinal Cord Syndrome (TSCS): Pathophysiology and clinical presentation with a focus on anaesthetic management

Physicoll collagen supplement supports holistic post-surgery recovery

Avicenna.AI lands FDA clearance for AI tool that detects cervical spine fracture

Scoliosis Research Society announces recipients for the Lifetime Achievement Award

24th-27th April 2025, NSpine Combined Cadaveric & Live Tissue Training; France

13-17 January 2025, NSpine Winter Masterclass; Switzerland

About Us

Subscribe

and receive all of the latest news via our weekly newsletter